JACC: CardioOncology - Dual Angiotensin Receptor Neprilysin Inhibition with Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-induced Cardiotoxicity
Dec 15, 2020
3:28
Episode Description
Commentary by Dr. Virginia Hahn
Commentary by Dr. Virginia Hahn
